Women who are already navigating the hormonal transition of menopause while using semaglutide face a compound challenge that requires careful monitoring
Orlistat is currently the only FDA-approved lipase inhibitor for weight loss
"We have demonstrated really for the first time that this class of medications used to treat type 2 diabetes and obesity may also have benefit for our patients who have asthma," said lead author Katherine Cahill, MD, medical director of Clinical Asthma Research in the Division of Allergy, Pulmonary, and Critical Care Medicine at VUMC
GLP-1 effects, including the appetite suppression most people notice first, activate at moderate potency but become more pronounced as doses increase during titration
The timeline for appetite suppression varies significantly between individuals , and some people do not notice clear changes until they titrate to 5 mg or higher